🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

25 recruiting trials

for Liver Cancer (Primary and Metastatic)

Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology NCT07303725n/a1 site📍 Palo Alto Palo Alto Veterans Institute for Research Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms NCT03981497n/a1 site📍 Milan Francesco De Cobelli · Tests: Microwave ablation (MWA) Hepatic and Systemic Hemodynamic Modeling During Liver Surgery NCT05339984NA1 site📍 Villejuif Assistance Publique - Hôpitaux de Paris · Tests: Partial hepatectomy (open approach), liver transplantation, Portal vein embolization Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma NCT03895359Phase 31 site📍 London London Health Sciences Centre Research Institute OR Lawson … · Tests: Stereotactic Body Radiation, Transarterial Chemoembolization Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance NCT07636148n/a3 sites📍 Lyon📍 Créteil📍 Leiden Mark C Burgmans, MD PhD Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA NCT05797077Phase 31 site📍 Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University · Tests: Colorectal resection surgery., FOLFOX chemotherapy regimen, Capecitabine Sapu003 in Advanced mTOR-sensitive Solid Tumors NCT07369505Phase 11 site📍 Adelaide SAPU NANO (US) LLC · Tests: Sapu003, Exemestane 25 MG Liver Embolization Approaches for Tumor Management NCT05714124n/a1 site📍 Milan IRCCS San Raffaele · Tests: Embolization Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment NCT07587216n/a1 site📍 Wuhan Tongji Hospital · Tests: liver resection, Systemic therapy combined with locoregional interventions Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EBNK-001 + IL-15 + Pembrolizumab Histotripsy for Ablation of Liver Tumours in Asia NCT07428356NA3 sites📍 Singapore📍 Singapore📍 Singapore National Cancer Centre, Singapore · Tests: Histotripsy using HistoSonics Edison™ System Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax NCT05092373Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel, Tumor Treating Fields Therapy Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer NCT04745390NA1 site📍 London London Health Sciences Centre Research Institute OR Lawson … · Tests: Radiation therapy Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype NCT06753136NA1 site📍 Padova Istituto Oncologico Veneto IRCCS · Tests: percutaneous, laparoscopic or laparotomy lesion electrochemotherapy SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774n/a68 sites📍 Birmingham📍 Mobile📍 Scottsdale Massive Bio, Inc. · Tests: Clinical Trial Matching Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies NCT07459309NA1 site📍 Shanghai Fudan University · Tests: Multimodal Tumor Thermal Ablation High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies NCT05053555NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: high dose rate brachytherapy, high dose rate brachytherapy Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer NCT01762813n/a1 site📍 Stavanger Helse Stavanger HF · Tests: open and laparoscopic surgery Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy NCT04982653Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Quality-of-Life Assessment, Surgical Procedure, Surgical Procedure Intravital Microscopy in Human Solid Tumors NCT03823144NA1 site📍 Jacksonville Mayo Clinic · Tests: Diagnostic Microscopy, Fluorescein Sodium Injection Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy NCT07445412n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna A Cohort Study (Risk Prediction of HCC in Patients With Chronic Liver Disease) NCT07820644n/a1 site📍 Shenzhen Cai Qingxian Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study) NCT06486454n/a33 sites📍 Fullerton📍 Los Angeles📍 Mission Viejo HistoSonics, Inc. · Tests: HistoSonics Edison System Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors NCT07410494Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EB-SELECT Single-Target CAR-NK Cells, Dual-Target Antigen-Selected CAR-NK
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy